n the gene NFl. Normally, NF1 functions to suppress tumor growth. Some patients with NF1 mutations respond to the FDA-approved therapy veramafinib (Zelboraf), whereas others do not. To better understand and predict on a molecular level the response of melanoma patients whose tumors contain NF1 mutations